Menu

噻托溴铵奥达特罗能倍乐的说明书

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Instructions for tiotropium bromide and olodaterol

Tiotropium bromide and olodaterol Respimat were developed by Boehringer Ingelheim. They are long-acting anticholinergic drugs that have selective inhibitory effects on M3 receptors. They have the advantages of long maintenance of blood concentration and minimal side effects. The specifications of each box are 60 puffs/bottle + 1 Respirnt inhalation device.

Product name: Spiriva Respimat

Generic name: tiotropium bromide spray

Main ingredients: tiotropium bromide

Indications: It is suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD, including chronic bronchitis and emphysema) and related dyspnea. It can improve the quality of life of COPD patients and reduce acute exacerbations of COPD.

Usage and dosage: Tiotropium bromide, olodaterol, and Respimat can only be used by inhalation. Bottles containing tiotropium bromide may only be used by inserting the Respimat inhalation device and inhaling it through the Respimat inhalation device. The recommended dose for adults is 2 puffs taken once daily via the Respimat inhaler device at the same time. Patients should not overdose.

Special groups: Elderly patients do not need to change the dosage. COPD rarely occurs in children, and the safety of the medication is unknown. Patients with renal insufficiency can use it at the recommended dosage. However, for patients with moderate to severe renal insufficiency (creatinine clearance ≤50ml/minute), the use of this product should be closely monitored. Patients with hepatic impairment do not require medication adjustments.

Adverse reactions: Common adverse reactions are dry mouth (3.2%), and serious adverse reactions include glaucoma, constipation, intestinal obstruction including paralytic ileus, urinary retention, etc.

Contraindications: Tiotropium and olodaterol should not be used in patients who are allergic to tiotropium bromide, atropine or their derivatives (such as ipratropium bromide, oxitropium bromide) or to any excipients of this product.

Recommended related hot articles: /newsDetail/83826.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。